好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Genetic Causal Associations between Obesity and Idiopathic Intracranial Hypertension (IIH): Mendelian Randomization (MR) study
Headache
S35 - Hot Topics in Headache (2:12 PM-2:24 PM)
007

IIH, pseudotumor cerebri, is an increased intracranial pressure leading vision changes and headaches. Obesity is a major risk factor, but the causal relationship was not proven. Previously SNP array in 95 IIH patients (Kuehn et al. 2019) showed 3 loci without obesity relevance.

To infer the genetic causality between obesity and IIH using genetic and phenotypic data from biobanks

Using TwoSampleMR packages for GWAS data, effect estimates were calculated using different method including the maximum likelihood, MR Egger, and inverse variance-weighted (IVW). Instrumental variables from GWAS summary stats were selected by different thresholds of p-value, linkage disequilibrium R2 (0.001), and clumping size. Exposure GWAS summary stats were derived from FinnGen, UK Biobank, and published data (e.g., GIANT consortium, NHGRI-EBI-GWAS catalog).

IIH GWAS summary stat included 16,380,402 SNPs in 102 European IIH cases (ICD-10 G93.2) was compared to 205,799 controls from FinnGen. Obesogenic traits showed a significant positive causal inference with IIH. They showed an odds ratio (OR) of 2.331 and 2.302 ([95%CI 1.057-5.143] and [1.054-5.027]) in maximum likelihood and IVW, respectively. Similar results were observed in other population datasets and consortia predominantly using the IVW: obesity and other hyperalimentation (OR 2.390 [1.119-5.104], p=0.024), childhood obesity (OR 2.558 [1.248-5.243], p=0.010), overweight (OR 2.577 [1.627-13.158], p=0.004), other obesity cohorts (OR 2.558 [1.247-5.244], p=0.036). Class III obesity (BMI >40) demonstrated a higher OR compared to class I obesity (BMI 30-35), with values of 2.311 [1.162-4.595] vs. 2.095 [1.052-4.170]) highlighting three notable variants: rs117280037, rs29939, and rs7973894. There was no evidence of horizontal pleiotropy nor heterogeneity supporting the robustness.

Our findings suggest the first evidence of genetic causal link between obesity and IIH, highlighting the importance of obesity control in managing IIH (Abbott et al. 2023, Neurology). Mechanistic studies on obesogenic genes and their interaction with other factors are warranted to understand the pathophysiology.

Authors/Disclosures
Hyunyong KOH, MD, PhD
PRESENTER
Dr. KOH has nothing to disclose.
Ryan Dhindsa, MD, PhD Dr. Dhindsa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AstraZeneca.
Seoyoung Park Seoyoung Park has nothing to disclose.
Woojae Myung Woojae Myung has nothing to disclose.
Hong-Hee Won Hong-Hee Won has nothing to disclose.
Daniel Calame, MD, PhD (Baylor College of Medicine, Child Neurology) Dr. Calame has nothing to disclose.
Michael E. Scheurer, PhD, MPH, FACE Dr. Scheurer has nothing to disclose.
Timothy E. Lotze, MD, FAAN (Texas Children's Hospital) Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.